Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

7476 results about "Microbial agent" patented technology

An antimicrobial is an agent that kills or inhibits the growth of microorganisms. The microbial agent may be a chemical compounds and physical agents.

Probiotic, lactic acid-producing bacteria and uses thereof

InactiveUS20060099197A1Good curative effectMitigating deleterious side-effectsAntibacterial agentsBiocideMicrobial agentAnti fungal
The present invention discloses compositions and methodologies for the utilization of probiotic organisms in therapeutic compositions. More specifically, the present invention relates to the utilization of one or more species or strains of lactic acid-producing bacteria, preferably strains of Bacillus coagulans, for the control of gastrointestinal tract pathogens, including antibiotic-resistant gastrointestinal tract pathogens, and their associated diseases by both a reduction in the rate of colonization and the severity of the deleterious physiological effects of the colonization of the antibiotic-resistant pathogen. In addition, the present invention relates to the utilization of therapeutic compounds comprised of lactic acid—producing bacteria and anti-microbial agents such as antibiotics, anti-fungal compounds, anti-yeast compounds, or anti-viral compounds. The present invention also discloses methodologies for: (i) the selective breeding and isolation of probiotic, lactic acid-producing bacterial strains which possess resistance or markedly decreased sensitivity to anti-microbial agents (e.g., antibiotics, anti-fungal agents, anti-yeast agents, and anti-viral agents); and (ii) treating or preventing bacteria-mediated infections of the gastrointestinal tract by use of the aforementioned probiotic bacterial strains with or without the concomitant administration of antibiotics. While the primary focus is on the treatment of gastrointestinal tract infections, the therapeutic compositions of the present invention may also be administered to buccal, vaginal, optic, and like physiological locations.
Owner:GANEDEN BIOTECH

Method for treatment and in-situ ecological restoration of black and stink riverway by using microorganism

The invention discloses a method for treatment and in-situ ecological restoration of a black and stink riverway by using microorganism. The invention is characterized in that target strains with pertinence are selected from sewage and then matched and combined with the existing strains to form compound microbial agents; and the sewage in the riverway is treated by using the matched compound microbial agents. In the invention, according to the specific pollution conditions of the riverway, the selected strains which are grown in the sewage are used to treat the sewage in the riverway, and the strains are matched and combined with the existing strains aiming at the pollution conditions of the water body in the riverway, so that the strains can exert synergistic effects in a microorganism sewage treatment system, thereby rapidly forming superior floras so as to decompose, absorb and transfer pollutants in the riverway and then achieving the optimum treatment efficiency. In the invention, the microorganism is firstly used to treat the water body, and then the water body is treated through the self-cleaning capability of the water body, thereby reaching the purpose of curing the exterior and the inherence and not generating secondary pollution. The method has the characteristics of safety, high efficiency, low cost, small investment and the like, and is simple to operate.
Owner:赵亚勋 +3

Compound microbial agent for degrading antibiotic and pesticide residues as well as preparation and application thereof

The invention relates to a compound microbial agent for degrading antibiotic and pesticide residues as well as preparation and application thereof, and belongs to the field of biotechnology and environmental protection. Multi-thallus compound microbial powder is prepared from the compound microbial agent according to the weight percentage of living microbes to the total amount of compound microbial powder as follows: 10%-15% of bacillus subtilis, 10%-15% of aspergillus niger, 10%-15% of bacillus mucilaginosus, 10%-15% of enterococcus faecalis, 8%-12% of bacillus licheniformis, 8%-12% of bacillus megaterium, 8%-12% of pseudomonas fluorescens, 5%-8% of lactobacillus plantarum, 5%-8% of bacillus polymyxin and 6%-8% of streptococcus thermophiles. The compound microbial agent has the effects of degrading antibiotic and pesticide residues, fermenting and composting organic matter, acting as functional fertilizer and repairing the environment, and can solve the problems of secondary pollution caused by antibiotic residues in culture feces and resource utilization of organic waste and realizes biodegradation of the antibiotic and pesticide residues in soil when applied to the agricultural ecological environment, thereby being of great value and practical significance in restoration of agricultural ecological environment and protection of human health.
Owner:中山市润泽生物科技有限公司

Absorbent substrate with a non-leaching antimicrobial activity and a controlled-release bioactive agent.

InactiveUS20080206293A1Inherent activityAntibacterial agentsBiocideHigh concentrationWound dressing
This invention relates to antimicrobial wound dressings having a non-leaching antimicrobial activity, releasable antimicrobial and antiprotease agents, and a controlled-release bioactive agent such as doxycycline. The Wound dressing material is absorbent and acts as a substrate for antimicrobial and antiprotease agents as well as bioactive agents. More generally, this invention relates to methods and compositions for materials having a non-leaching coating that has antimicrobial properties. The coating is applied to substrates such as gauze-type wound dressings, powders and other substrates. Covalent, non-leaching, non-hydrolyzable bonds are formed between the substrate and the polymer molecules that form the coating. A high concentration of anti-microbial groups on multi-length polymeric molecules and relatively long average chain lengths, contribute to an absorbent or superabsorbent surface with a high level antimicrobial efficacy. Utilization of non-leaching coatings having a plurality of anionic or cationic sites is used according to this invention to bind a plurality of oppositely charged biologically or chemically active compounds, and to release the bound oppositely charged biologically or chemically active compounds from said substrate over a period of time to achieve desired objectives as diverse as improved wound healing to reduction in body odor.
Owner:QUICK MED TECH +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products